FDA Center for Drug Evaluation & Research Issues Warning Letter to PReye
September 02, 2026
September 02, 2026
WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to PReye LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Dr. Melinda C. O'Rourke, Owner, PReye, LLC, 4855 Ward Rd., Wheat Ridge, CO 80033, United States, (b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
Reference number . . .
* * *
Recipient: Dr. Melinda C. O'Rourke, Owner, PReye, LLC, 4855 Ward Rd., Wheat Ridge, CO 80033, United States, (b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
Reference number . . .
